PSN Extra
ASPS statement on Breast Implant Associated-Squamous Cell Carcinoma (BIA-SCC)
Thursday, September 8, 2022On Sept. 8, 2022, the Food and Drug Administration (FDA) released a new safety communication about squamous cell carcinoma (SCC) and various lymphomas in the capsule around breast implants.
Gluteal Fat Grafting: A joint safety statement
Thursday, August 18, 2022Gluteal fat grafting, commonly known as "Brazilian Butt Lift" or BBL, has seen an increase in popularity in recent years. It is well-recognized that this procedure carries significant risk compared to other elective aesthetic surgical procedures and as a result, its increased popularity has resulted in deeply concerning levels of patient harm and mortality.
ASPS innovation partner MTI offers webinar series for start-ups and interested members
Thursday, August 18, 2022A webinar series by MedTech Innovator (MTI), the largest accelerator of medical devices in the world, offers medical start-ups and interested members an educational resource to help bring ideas to market.
Remembering a pillar of plastic surgery, David Furnas, MD, 1931-2022
By Paul Snyder Wednesday, August 17, 2022Plastic surgeons are paying tribute to David Furnas, MD, who passed away Aug. 15. He was 91.
Award highlights the educational importance of "The Innovators"
By Paul Snyder Monday, August 15, 2022"By Design: Breast Reconstruction," an episode of "The Innovators" series, earned Jeff Madden, the Society's staff media producer, and ASPS its first-ever Telly Award earlier this year. The national Telly Awards honor excellence in video across all screens.
ASPS membership provides discounted registration for Houston breast surgery conference
Thursday, July 28, 2022The 8th International Breast Surgery Workshop (IBSW) and 4th World Consensus Conference on BIA-ALCL (WCC-BIAALCL) joint meetings to be hosted by MD Anderson Cancer Center in Houston on Sept. 30 and Oct. 1 at the Texas Medical Center Intercontinental Hotel, and ASPS members are invited to take advantage of a discounted registration fee.
'I'm going back – I need to see if I can help': ASPS member recounts Highland Park horror
By Paul Snyder Thursday, July 7, 2022At first, ASPS member Loren Schechter, MD, thought kids were setting off fireworks. Then he noticed the tree he was standing under was shaking. Then he smelled the gun powder.
PRS hits Impact Factor record high for fifth time in six years
By Jim Leonardo Friday, July 1, 2022InCites, a web-based research evaluation benchmarking and analytics tool, released its 2022 Journal Citation Report, revealing that Plastic and Reconstructive Surgery once again bested its Impact Factor from the previous year with an all-time high of 5.169 and was cited 47,800 times in 2021.
FDA recognizes The PSF-supported FACE-Q as a Medical Device Development Tool
By Paul Snyder Tuesday, May 3, 2022The FDA last week announced that it had accepted the FACE-Q as a qualified Medical Device Development Tool (MDDT) – a decision that not only provides the agency with patient perspective when it comes to evaluating new aesthetic treatments, but also national recognition for an idea that came into being thanks to The PSF's grant funding.
Remembering John Tebbetts, MD
By Steve Byrd, MD Monday, April 18, 2022Steve Byrd, MD, and fellow ASPS members pay tribute to John Tebbetts, MD, who passed away in March at age 75. Dr. Tebbetts is remembered as a "perfectionist in all things that he pursued."
View All for 2022
